Average Co-Inventor Count = 7.10
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (37 from 378 patents)
2. Bayer Intellectual Property Gmbh (25 from 721 patents)
3. Schering Aktiengesellschaft (9 from 1,384 patents)
4. Bayer Schering Pharma Ag (4 from 192 patents)
5. Sterix Limited (4 from 51 patents)
6. Bayer Aktiengesellschaft (2 from 12,160 patents)
7. Bayer Pharma Aktiengesellscaft (1 from 1 patent)
77 patents:
1. 11976334 - Inhibitor of ATR kinase for use in a method of treating a hyper-proliferative disease
2. 11712440 - Predictive markers for ATR kinase inhibitors
3. 11660301 - Combination of ATR kinase inhibitors with PARP inhibitors
4. 11529356 - 2-(morpholin-4-yl)-1,7-naphthyridines
5. 10772893 - 2-(morpholin-4-yl)-1,7-naphthyridines
6. 10729680 - 5-substituted 2-(morpholin-4-yl)-1,7-naphthyridines
7. 10717749 - Macrocyclic sulfondiimine compounds
8. 10604532 - Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases
9. 10428044 - 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
10. 10428063 - 4H-pyrrolo[3,2-C]pyridin-4-one derivatives
11. 10350206 - Benzyl substituted indazoles as BUB1 inhibitors
12. 10308629 - 1H-pyrrol-3-amines
13. 10266548 - Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases
14. 10227299 - 3-amino-1,5,6,7-tetrahydro-4H-indol-4-ones
15. 10214542 - Modified macrocyclic compounds